SAMSARA BIOCAPITAL, LLC
CIK 1744967 · Holdings on Sep 30, 2023 · First reported Nov 14, 2023
Top ten holdings
Q3 2023- MLYS13.16%
- RYZB12.54%
- SRRK9.99%
- SLRN7.41%
- ACLX6.74%
- GRPH6.42%
- ICPT3.64%
- LYRA3.33%
- 43157M1023.29%
- 05337M1043.05%
Share classes counted separately69.57%
Portfolio value by quarter
Top 10 holdings 30
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | MLYSMINERALYS THERAPEUTICS INC View history and evidence | $42.98M | 13.16% | 4.52M shares | — | ↗▾ | |
| 02 | RYZBRAYZEBIO INC View history and evidence | $40.98M | 12.54% | 1.85M shares | — | ↗▾ | |
| 03 | SRRKSCHOLAR ROCK HOLDING CORP View history and evidence | $32.65M | 9.99% | 4.60M shares | — | ↗▾ | |
| 04 | SLRNACELYRIN INC View history and evidence | $24.22M | 7.41% | 2.38M shares | — | ↗▾ | |
| 05 | ACLXARCELLX INCCOMMON STOCK View history and evidence | $22.03M | 6.74% | 613.92K shares | — | ↗▾ | |
| 06 | GRPHGRAPHITE BIO INC View history and evidence | $20.98M | 6.42% | 8.46M shares | — | ↗▾ | |
| 07 | ICPTINTERCEPT PHARMACEUTICALS IN View history and evidence | $11.88M | 3.64% | 640.69K shares | — | ↗▾ | |
| 08 | LYRALYRA THERAPEUTICS INC View history and evidence | $10.87M | 3.33% | 2.78M shares | — | ↗▾ | |
| 09 | 43157M102HILLEVAX INC View history and evidence | $10.75M | 3.29% | 799.27K shares | — | ↗▾ | |
| 10 | 05337M104AVADEL PHARMACEUTICALS PLCSPONSORED ADR View history and evidence | $9.97M | 3.05% | 967.53K shares | — | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 9
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| 16961L106 CHINOOK THERAPEUTICS INC | Non-derivative | — | — | SEC filing ↗ | |
| OPHT IVERIC BIO INC | Non-derivative | — | — | SEC filing ↗ | |
| 23345J104 DICE THERAPEUTICS INC | Non-derivative | — | — | SEC filing ↗ |
3 / 9 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1744967 · Period 2023-09-30
Data loaded 2026-09-23 · First reported 2023-11-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 326684744
}Research all 41 reported holdings.
This page includes 30 of 41 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 41 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1744967","quarter":"2023Q3","page_size":100}
get_institutional_manager_history
{"cik":"1744967","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.